We conducted a systematic literature review using MEDLINE and 
A b s t r a c t

We conducted a systematic literature review using MEDLINE and Embase to identify articles on diagnostic accuracy of frozen section (FS) for salivary gland lesions published between
. We also reviewed the reference lists of all identified articles and conducted a forward search using Scopus to identify all articles citing the reference set. Meta-analysis was used to produce a summary receiver operating characteristic (SROC) curve from which summary estimates of sensitivity and specificity were obtained. Study quality was assessed using the Quality of Diagnostic Accuracy Study (QUADAS) The diagnosis and treatment of salivary gland lesions proceeds in stages. In the initial stage, clinical, radiologic, and fine-needle aspiration cytology (FNAC) are used to categorize cases into surgical or nonsurgical groups ❚Figure 1❚ (decision 1). In general, patients with neoplastic disease are referred for surgical treatment, whereas patients with nonneoplastic disease receive other modes of treatment. In the second stage, neoplastic lesions must be categorized as benign or malignant, which influences the type and extent of surgery ( Figure 1 , decision 2). For example, the facial nerve can be spared in benign lesions. Thus, 2 important decisions rest on the initial diagnosis: (1) whether surgical treatment is required and (2) the type and extent of surgery.
FNAC has a well-established role in the initial, preoperative diagnosis of salivary gland lesions. It is safe, fast, well-tolerated, and minimally invasive; however, it is known to have several deficiencies. On average, FNAC has high specificity (97%), but the sensitivity is somewhat lower (80%). 1 Thus, a positive diagnosis by FNAC is quite reliable, but the false-negative rate associated with FNAC (20%) may be unacceptable. In addition, the accuracy of FNAC varies widely across practice sites. 1 Thus, there is a need to improve the reliability of FNAC.
Frozen section (FS) provides an opportunity to refine the presurgical diagnosis among patients who have been referred to surgery. FS is used for 3 general purposes 2 in the evaluation of salivary gland lesions: (1) clarify diagnosis, (2) check operative margins, and (3) determine whether nerve or neck involvement is present. FS would be routinely used in cases with a presurgical malignant diagnosis to check margins and assess nerve involvement, but the value of FS is less certain when the presurgical diagnosis is benign. In such cases, FS is used to refine the diagnosis (Figure 1, decision 3) , and, when used for this purpose, the usefulness of FS depends on the accuracy of FS and the accuracy of the presurgical diagnosis. Overall, FS can provide information that may supplement other diagnostic methods (eg, imaging and FNAC) or provide information that is complementary or unique to FS (eg, assessment of margins). Although FS provides multiple types of information that can be evaluated for accuracy, this review is concerned with the accuracy of FS for the classification of lesions with respect to malignancy.
When used for diagnosis, FS can be used in several ways. First, FS can clarify diagnoses when other modes of preoperative diagnosis are inadequate or inconclusive. In such cases, FS is used as a stand-alone technique to provide a diagnosis. FS can also be used more routinely to confirm or refine a presurgical diagnosis. Although FS adds additional information, the incremental value of FS relative to other modes of preoperative diagnosis has not been determined, and it is unclear whether FS should be used routinely or limited to certain circumstances. In particular, the roles of FS and FNAC have been controversial. Some authors have concluded that FS is more reliable than FNAC and that FS should be used routinely to ensure the best patient management. 3 Others have concluded that FNAC and FS have similar accuracy and that both have a role in the evaluation of salivary gland lesions. 4 The answers to questions about the routine use of FS vs the use of FS only in specific circumstances require an accurate assessment of the relative diagnostic performance of presurgical diagnosis and FS.
The diagnostic accuracy of FS performance has significant implications for the surgical management of parotid tumors. Surgery is the preferred treatment of most neoplasms of the parotid. However, the extent of treatment differs based on the histopathologic type of neoplasm. Historically, the concerns of false-negatives with FNAC led to its minimal use in preoperative decision making. Thus, intraoperative decisions were based on FS analysis or on final histopathologic diagnoses with the potential of revision surgery. 5 Intraoperative FS may increase the extent of parotidectomy based on a malignant diagnosis and even determine the need for facial nerve sacrifice or the addition of a neck dissection. Thus, understanding the accuracy of FS has significant implications for its use in the intraoperative setting. Systematic reviews are the foundation of evidencebased medicine and provide the basis for the development of guidelines for patient management. Numerous studies on the accuracy of FS for the diagnosis of parotid tumors have been published; however, this body of literature has never been adequately summarized. Although some studies have summarized selected results, the literature on FS has not been systematically reviewed. We recently completed a systematic review and meta-analysis on the diagnostic accuracy of FNAC for parotid gland lesions. 1 Our objective in this study was to conduct a similar review on the diagnostic accuracy of FS and to compare the accuracy of FS with FNAC for diagnosis of malignancy. To that end, we conducted a systematic review of the literature and used meta-analysis to develop a summary receiver operating characteristic (SROC) curve for the diagnostic performance of FS in the evaluation of parotid gland tumors. We also conducted a quality assessment of included articles to explore potential sources of bias and to provide recommendations to improve future studies. 
Materials and Methods
We followed current guidelines for systematic review and meta-analysis of diagnostic studies. 6, 7 A glossary of terms is provided in ❚Appendix 1❚. 8, 9 
Literature Search
We searched MEDLINE and Embase for studies evaluating the diagnostic accuracy of FS for parotid lesions published between January 1, 1985, and October 15, 2010, using a sensitive search strategy developed in consultation with an experienced medical reference librarian. Our search strategy was broad and included articles on head and neck lesions in addition to salivary glands. Language was not restricted. Scopus was used to perform a forward search to obtain articles citing the set of included articles. The references of all included articles were also searched to obtain additional studies.
Eligibility
Titles and abstracts were evaluated independently by 2 of us (R.L.S. and B.J.H.) for eligibility. Studies were eligible if they seemed to contain data on the diagnostic accuracy of FS for salivary gland tumors or head and neck tumors. Prospective and retrospective studies were eligible. Full reprints were obtained for all eligible studies.
Inclusion
Eligible studies were independently evaluated by 2 of us (R.L.S. and B.J.H.), and discrepancies were resolved by consensus. Studies were included if they contained accuracy data for the diagnosis of parotid gland lesions, contained histologically verified cases that could be extracted, and provided data that enabled lesions to be classified into broad categories (malignant vs benign).
We excluded case reports and studies with fewer than 10 cases. Eligible studies were included if accuracy data could be extracted in the form required for analysis (true-positives, false-positives, false-negatives, and true-negatives).
Data Extraction
Data extraction was completed independently by 2 of us (R.L.S. and B.J.H.), and discrepancies were resolved by consensus or by correspondence with authors of the study in question. Data from foreign-language articles (non-English) were extracted by pathologists with knowledge of the language, correspondence with study authors, or by a translator working in conjunction with one of us (R.L.S.). Inadequate or indeterminate biopsies were not counted in the calculation of accuracy. Diagnoses of "suspicious for malignancy" or "atypical" were counted as malignant. When results of a study were published more than once, we included only the most complete data. Non-salivary gland tumors (eg, lymphoma and metastases) were included in the analysis.
Quality Assessment
Quality assessment of articles written in English was conducted by using QUADAS. 10 Assessment was completed independently by 2 of us (R.L.S. and B.J.H.). We used a scoring form that we developed in our study of FNAC. 1 We reviewed items with discrepant scores. Discrepancies due to errors and misinterpretations were corrected. Discrepancies sometimes arose owing to differences in judgment. We discussed these items until consensus was reached. The consensus approach was infrequently required because the initial level of agreement was high.
Statistical Analysis
SROC curves were developed by using the hierarchical inverse-variance-weighted meta-analysis. We created new variables containing the diagnostic accuracy estimates and standard errors for each study. 8, 11 Computations were done using Stata Statistical Software, Release 11 (2009; StataCorp, College Station, TX) and applying the metandi procedure. 12 We used the inconsistency (I 2 ) statistic to measure heterogeneity across studies. Heterogeneity is a measure of the between-study variation in studies and is used to assess whether the studies in a meta-analysis represent a single population (with similar accuracy) or several different populations.
Results
Literature Search
We screened 3,848 titles and abstracts to obtain a set of 551 eligible articles. The text of the eligible studies was screened to obtain 13 studies that met our inclusion criteria ❚Table 1❚. [2] [3] [4] [5] [13] [14] [15] [16] [17] [18] [19] [20] [21] These studies included a total of 1,880 cases on the discrimination of benign vs malignant lesions.
Diagnostic Accuracy
The SROC curve for discrimination of benign and malignant lesions is shown in ❚Figure 2❚, and the accuracy estimates are given in ❚Table 2❚. FS has higher specificity than sensitivity. In addition, there is more variability in sensitivity than in specificity ❚Figure 3❚. A test for study heterogeneity, I 2 , was not significant (P = .06). The rate of inadequate or inconclusive results was 3.7% among the studies that reported such results.
Quality Assessment
A summary of the QUADAS quality assessment is given in ❚Table 3❚. All studies were retrospective. The only QUA-DAS items that had variable results were items 1 (inclusion criteria), 2 (representativeness), and 13 (inconclusive results explained). All other items were identical among studies.
Discussion
The overall accuracy of FS is quite good. It has high specificity (0.99), and, although the sensitivity is not as high (0.90), we believe it is clinically acceptable.
Sources of Bias and Heterogeneity
The degree of heterogeneity we observed in this collection of studies was borderline insignificant (P = .06).
Tests for heterogeneity are known to be insensitive, so it is possible that there is some undetected heterogeneity in our collection of studies. In general, performance variation can be attributed to 4 factors: real differences between tests (population, test performance, reference test, and outcome measure), threshold effects, bias, and random variation. Understanding the causes of performance variation is important because it provides a basis to improve consistency and improve diagnostic performance.
Threshold Effects
Our statistical analysis suggests that most of the performance variation is due to threshold effects. In general, variation in a direction tangent to the SROC curve can be attributed to threshold effects, whereas variation in the direction perpendicular to the tangent of the SROC curve can be attributed to accuracy. In the evaluation of FS, a difference in accuracy would mean that pathologists differ in their ability to detect features and to interpret them correctly. A difference in threshold would mean that pathologists see the same features but use different criteria for diagnosing malignancy. As shown in Figure 2 , almost all of the studies lie along the SROC curve, and the estimated percentage of variation due to threshold effects is close to 100%. Threshold effects have been recognized as an important source of variation in other studies. 22 Such variation might be minimized by more uniform application of diagnostic criteria.
Sources of Bias
The purpose of a quality assessment is to identify potential sources of bias and to estimate their impact. We identified 3 potential sources of bias: classification bias (item 3, Table 3 ), review bias (item 11, Table 3 ), and handling of inconclusive or inadequate results (item 13, Table 3 ).
Misclassification bias results from an imperfect reference test (ie, definitive histologic examination). There are All of the studies we included were retrospective studies using data obtained under actual clinical conditions. Pathologists were not blinded to the results of FS when making the final diagnosis. Thus, there is some potential for FS results to influence the interpretation of the reference test. This diagnostic review bias would tend to increase sensitivity and specificity; however, we believe that this effect is relatively minor because final histologic study is generally weighed much more heavily than FS when making a final diagnosis.
Inconclusive results can have a significant impact on accuracy statistics. Thus, it is important that such results are reported in a consistent manner. The percentage of inconclusive or inadequate results was 3.7% for FS in our set of studies. This finding is in contrast with an inconclusiveinadequacy rate between 8.1% and 9.5% that we found in our review of FNAC. 1 It is important that studies report inconclusive and inadequate results and report them in a standard format to facilitate comparisons between studies. This is an area requiring improvement.
There are a few additional areas in which improved reporting or study design would reduce potential bias. In some cases, authors could improve descriptions of the criteria used to select patients. In particular, it is important for authors to indicate whether the study included only consecutive patients from a given period. Diagnostic performance is sensitive to subtle effects related to referral patterns, so it is also important for authors to provide a brief description of the patient population. Although the patient populations were not described in some studies, we saw no studies in which referral patterns were likely to be problematic.
Unlike FNAC studies, verification bias (QUADAS item 5) is not a source of bias in FS studies because all samples (negative and positive) are referred for definitive histologic examination. Thus, we do not believe that verification bias is an important source of bias in the studies we included in our analysis.
Random Variation
The I 2 statistic indicates that 53% of the variation is due to between-study variation (real differences between studies) and that the remainder is attributable to within-study, or random variation. The within-vs between-study variation is shown in Figure 3 . This result is in contrast with the high level of performance variation seen in FNAC, in which 98% of the variation was estimated to be due to between-study variation. 1 Overall, the variability in sensitivity seen between FS studies is most likely due to a combination of threshold differences and random variation. The studies were homogeneous with respect to real differences (population, index test performance, reference test performance, and outcome measures), so this is an unlikely source of variation. We identified only minor potential sources of bias (review bias and misclassification bias). These sources of bias would tend to be fairly uniform across studies and would most likely lead to an underestimate of sensitivity.
Comparison of the Accuracy of FS and FNAC
We use the findings from our previous study of the diagnostic accuracy of FNAC 1 for the diagnosis of parotid gland lesions for comparison with FS diagnosis of lesions in the same anatomic location. ❚Figure 4❚ The effect of misclassification on the observed sensitivity and specificity. Summary totals for all included studies (Table 4) were used as a reference. The values shown in the graph are the calculated sensitivity and specificity relative to the initial sensitivity and specificity in Table 4 . For example, the sensitivity based on the summary totals is 0.85. At a misclassification rate of 0.05, the observed sensitivity would be 0.72. The sensitivity shown in the graph is the ratio of the observed sensitivity to the actual sensitivity, 0.72/0.85 = 0.85.
considerable morphologic overlap, making cytologic distinction difficult. These neoplastic types include cellular pleomorphic adenomas, monomorphic adenomas (especially basal adenomas), low-grade mucoepidermoid carcinomas, adenoid cystic carcinomas, and polymorphous low-grade adenocarcinomas. Nuclear features of these neoplasms may overlap, making cytologic separation difficult. In addition, in some aspiration specimens, there are insufficient architectural clues for definitive diagnosis. Properly performed FS has the advantage over FNAC in that architectural features such as capsular and perineural invasion are retained and when present favor carcinoma or adenoma. The retention of architectural clues in FS specimens undoubtedly improves the sensitivity and specificity of FS in comparison with FNAC. FS provides valuable information for surgeons and intraoperative decision making because it often determines the extent of treatment of parotid neoplasms. On the most basic level, it is important to distinguish malignant from benign disease.
Benign disease often requires only partial parotidectomy, frequently superficial parotidectomy. Even limited tumor resection with preservation of normal parotid tissue has been proposed as adequate treatment for benign disease. 24, 25 With a sensitivity of fine-needle aspiration biopsy near 80%, FS provides additional confirmation of benign disease during resection that allows for limited surgery.
For malignant parotid disease, difficult decisions are made intraoperatively, including management of the facial nerve and regional lymph nodes. While sacrificing the facial nerve is not necessary in benign disease, involvement of the facial nerve by malignancy will require sacrifice of 1 or more branches of the nerve. Preoperative dysfunction of the facial mimetic muscles is indicative of tumor involvement of the facial nerve, but there may be nerve involvement in people with normal preoperative facial movement. A malignant diagnosis increases a surgeon's comfort level in the indication for facial nerve sacrifice, and this may require an FS diagnosis.
After a portion of the facial nerve is resected, FS is used to ensure proximal and distal control of the perineural tumor spread before a primary neural reconstruction. When FS identifies tumor at the stylomastoid foramen, a mastoidectomy may be required to control the proximal facial nerve margin. In regard to management of regional lymph nodes, an FS diagnosis of malignant disease, other than low-grade disease, requires treatment of the regional lymphatics by neck dissection or irradiation. 26, 27 Several authors favor a neck dissection in the treatment of regional lymphatics when the parotid mass is known to be malignant. 28, 29 For people with a history of squamous cell carcinoma of the skin, an FS diagnosis of squamous cell carcinoma is diagnostic of regional lymphatic disease necessitating a neck dissection in addition to the parotidectomy for the treatment of regional
The area under the SROC (AUSROC) curve is a measure of accuracy that can be used to compare 2 different methods. The diagnostic accuracy of FS (AUSROC, 0.99; 95% confidence interval [CI], 0.98-1.00) is significantly higher than the diagnostic accuracy of FNAC (AUSROC, 0.96; 95% CI, 0.94-0.97). The specificity of FS is quite high (0.99). The specificity values of FS and FNAC are both clinically acceptable (0.99 for FS vs 0.97 for FNAC). Thus, a positive result obtained by either technique is quite reliable. As with FNAC, the sensitivity of FS is lower than the specificity. While the sensitivities of FS and FNAC are not statistically significantly different, the sensitivity of FS was slightly higher (0.90; 95% CI, 0.81-0.94) than the sensitivity of FNAC (0.80; 95% CI, 0.75-0.83). Thus, FS might be used to refine the diagnosis of cases referred to surgery with a nonmalignant diagnosis by FNAC (Figure 1, decision 3) .
A possible policy would be to accept an FNAC diagnosis of malignant as correct but to check an FNAC diagnosis of benignancy and to use FS only to check the cases referred to surgery. Assuming that FNAC and FS are independent, the overall sensitivity and specificity of such a policy would be 0.98 and 0.95, respectively, and would cut the false-negative rate from 20% (FNAC only) to 5% (combined FNAC and FS). Although such a policy has the potential to reduce false-negatives, it would also increase costs by increasing the rate of use of FS; however, clinical and radiologic analysis will often support or call into question the fine-needle aspiration and guide the decision on the need for a post-FNAC FS. The trade-offs should be investigated through a formal cost-effectiveness analysis.
The performance variability (heterogeneity) seen in our study of FS is much less than the heterogeneity seen in our previous study of FNAC. 1 The I 2 statistic 23 is a measure of the percentage of total performance variability that can be attributed to between-study variability vs within-study variability that results from the natural underlying error rate. For FS, the inconsistency statistic was 53% (CI, 0%-100%) and was not statistically significant. In contrast, the inconsistency statistic for FNAC was highly significant at 98% (CI, 97%-99%). Thus, there is much greater between-study variability for FNAC than for FS. We were unable to determine the reason for the high level of heterogeneity seen in FNAC studies; however, our results suggest that the diagnostic accuracy of FNAC may be more operator-dependent than FS.
Salivary gland neoplasms are diagnostically challenging at the time of FNAC interpretation and FS analysis. Many salivary gland neoplasms have cytologically low-grade nuclear morphologic features. Thus, interpretation of FNAC material relies on the evaluation of tumor fragments with retained architectural features and extracellular and intracellular materials (mucin and myxoid matrix) for identification of several tumor types. Certain neoplasms demonstrate
Conclusions
The overall accuracy of FS is clinically acceptable (90% sensitivity, 99% specificity) and shows consistent results between study centers. The accuracy of FS is somewhat higher than that of FNAC. It could be used to confirm a ❚Appendix 1❚
Glossary of Terms Term Definition
Area under the curve (AUC) A measure of diagnostic accuracy that is independent of a particular threshold or cutoff point. In general, it is difficult to compare diagnostic accuracy between studies because differences could represent real differences in accuracy (ability to detect features) or differences in threshold. The AUC represents the average sensitivity for all levels of specificity and thereby removes threshold effects. The AUC is a valid method to compare the diagnostic accuracy of tests because it removes the effect of the choice of threshold. The AUC is the region that underlies the ROC curve or the SROC curve and varies between 0.5 (no discrimination) to 1.0 (perfect discrimination). Bias A systematic difference between an observed measurement and the true value. For a diagnostic accuracy study, bias occurs when there is a methodological factor that leads to a systematic difference between the observed sensitivity and specificity vs the true sensitivity and specificity. Common sources of bias in diagnostic studies include verification bias, spectrum bias, misclassification bias, and review bias. Embase An electronic database similar to PubMed but with broader coverage of foreign language journals, particularly in Europe. Forward search A search to identify more recent studies that have cited a set of known publications. A forward search is also known as a citation search. Citation databases include Scopus, Google Scholar, Web of Knowledge, and the Ovid interface for MEDLINE. Heterogeneity A measure of the between-study variation in studies. Measures of heterogeneity assess whether the included studies represent a single population (with similar diagnostic accuracy) or several different populations with different diagnostic performance. For example, a homogeneous set of studies might have sensitivities and sensitivities clustered around 80 and 80 whereas a heterogeneous set of studies might have 2 clusters of studies centered around sensitivity and specificity values of 60 and 65 and 95 and 90. The assessment of heterogeneity is an important component of meta-analysis and can lead to the identification of factors that cause variation in diagnostic accuracy between study centers. Hierarchical analysis Hierarchical models are a generalization of multiple linear regression. In multiple regression, an outcome variable is modeled at a single level. For example, y = a + bx, where a and b are parameters that are determined by best fit techniques. In hierarchical regression, models are also constructed for the coefficients (eg, a = c + dz). In this study, we used a hierarchical model 8 to construct a summary ROC curve. At one level, we model the variation within studies and, at another level, we model the variation between studies. The STATA metandi function applies the method of Macaskill 9 to formulate a summary ROC curve. Inconsistency statistic (I 2 )
A statistical measure of heterogeneity that varies from 0 to 100. The value describes the proportion of total variation in study results that is due to heterogeneity rather than chance. A value of 0 means that the set of studies is homogeneous and the observed variation is due to chance (random variation), whereas a value of 100 means that the observed variation between studies is due to heterogeneity.
Index test
Refers to the test under study. In the present study, FNAC is the index test, and histologic examination is the reference test. Meta-analysis A method for combining study results to obtain better estimates (by increasing sample size) and to investigate factors that cause variability in study results. Metandi A procedure for meta-analysis of diagnostic accuracy studies that is contained in Stata. Stata is a general purpose statistical package.
Misclassification bias
Results from errors in the reference test (the "gold standard"). In FNAC studies, the reference test is histologic examination or clinical follow-up. Neither of these reference standards is error-free. Errors in the reference standard can lead to systematic differences (bias) in the observed sensitivity and specificity of the index test (FNAC).
FNAC, fine-needle aspiration cytology; ROC, receiver operating characteristic.
